D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$570M |
| 2 |
Meta Platforms (Facebook)
META
|
+$469M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$342M |
| 4 |
Merck
MRK
|
+$322M |
| 5 |
MON
Monsanto Co
MON
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$434M |
| 2 |
Netflix
NFLX
|
+$301M |
| 3 |
Alibaba
BABA
|
+$245M |
| 4 |
Verizon
VZ
|
+$235M |
| 5 |
Tesla
TSLA
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.27% |
| 2 | Healthcare | 11.28% |
| 3 | Consumer Discretionary | 8.99% |
| 4 | Communication Services | 8.03% |
| 5 | Industrials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
VSE Corp
VSEC
$5.48B
| $1M | ﹤0.01% |
20,685
-2,433
| -11% | -$125K |
|
2527
Pacira BioSciences
PCRX
$1.02B
| $1M | ﹤0.01% |
21,900
+12,049
| +122% | +$478K |
|
2528
Natural Health Trends
NHTC
$15.4M
| $997K | ﹤0.01% |
65,640
+40,258
| +159% | +$759K |
|
2529
Stepan Co
SCL
$1.31B
| $997K | ﹤0.01% |
12,628
-2,164
| -15% | -$178K |
|
|
LADR
2530
Ladder Capital
LADR
$1.25B
| $994K | ﹤0.01% |
72,901
-210,651
| -74% | -$2.88M |
|
2531
CALL
Truist Financial
TFC
$63.2B
| $994K | ﹤0.01% |
20,000
| – | – |
|
2532
PUT
Regions Financial
RF
$26.3B
| $987K | ﹤0.01% |
57,100
| – | – |
|
2533
Novanta
NOVT
$5.04B
| $986K | ﹤0.01% |
19,722
-48,344
| -71% | -$2.36M |
|
|
SIGM
2534
DELISTED
Sigma Designs Inc
SIGM
| $984K | ﹤0.01% |
141,627
+14,998
| +12% | +$94K |
|
2535
UBS Group
UBS
$170B
| $983K | ﹤0.01% |
+53,478
| New | +$929K |
|
2536
Steris
STE
$20.9B
| $981K | ﹤0.01% |
11,217
-12,824
| -53% | -$1.14M |
|
|
CRC
2537
DELISTED
California Resources Corporation
CRC
| $981K | ﹤0.01% |
+50,464
| New | +$708K |
|
|
MOMO
2538
CALL
Hello Group
MOMO
$869M
| $979K | ﹤0.01% |
+40,000
| New | +$1.15M |
|
2539
CALL
Alaska Air
ALK
$5.15B
| $978K | ﹤0.01% |
13,300
+3,300
| +33% | +$235K |
|
|
ONC
2540
PUT
BeOne Medicines Ltd
ONC
$33.8B
| $977K | ﹤0.01% |
+10,000
| New | +$915K |
|
2541
DMC Global
BOOM
$121M
| $976K | ﹤0.01% |
38,969
-35,209
| -47% | -$723K |
|
2542
CALL
Visteon
VC
$2.77B
| $976K | ﹤0.01% |
7,800
| – | – |
|
|
GHL
2543
PUT
DELISTED
Greenhill & Co., Inc.
GHL
| $975K | ﹤0.01% |
50,000
| – | – |
|
2544
Lindsay Corp
LNN
$1.16B
| $972K | ﹤0.01% |
11,025
-14,276
| -56% | -$1.3M |
|
|
WOW
2545
DELISTED
WideOpenWest
WOW
| $971K | ﹤0.01% |
91,849
-74,424
| -45% | -$875K |
|
|
BBG
2546
DELISTED
Bill Barrett Corp
BBG
| $971K | ﹤0.01% |
189,322
-91,621
| -33% | -$469K |
|
|
IMMU
2547
PUT
DELISTED
Immunomedics Inc
IMMU
| $970K | ﹤0.01% |
+60,000
| New | +$708K |
|
2548
Resources Connection
RGP
$129M
| $969K | ﹤0.01% |
62,688
-32,362
| -34% | -$500K |
|
|
SVM
2549
Silvercorp Metals
SVM
$2.13B
| $969K | ﹤0.01% |
371,644
+66,764
| +22% | +$170K |
|
2550
CALL
New Oriental
EDU
$7.84B
| $968K | ﹤0.01% |
10,300
| – | – |
|
Similar funds
D.E. Shaw & Co's Q4 2017 Portfolio in Review
As of Q4 2017, D.E. Shaw & Co held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $434M trimmed.
- D.E. Shaw & Co's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
- D.E. Shaw & Co added most to GE Aerospace in Q4 2017, an estimated $570M increase.
- D.E. Shaw & Co's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
- D.E. Shaw & Co fully exited Tesla in Q4 2017, selling an estimated $230M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
- D.E. Shaw & Co opened 507 new positions and closed 394 in Q4 2017.
- D.E. Shaw & Co's portfolio value rose 12% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.